Outcomes of single‑lead VDD pacemakers in atrioventricular blocks: The OSCAR study.

Atrial myopathy Atrial sensing Atrio-ventricular block Interatrial-block Left atrial function VDD pacemaker

Journal

International journal of cardiology
ISSN: 1874-1754
Titre abrégé: Int J Cardiol
Pays: Netherlands
ID NLM: 8200291

Informations de publication

Date de publication:
15 02 2021
Historique:
received: 31 03 2020
revised: 17 06 2020
accepted: 22 09 2020
pubmed: 29 9 2020
medline: 28 5 2021
entrez: 28 9 2020
Statut: ppublish

Résumé

VDD pacemakers are regarded as a second choice in patients with atrio-ventricular blocks mainly due to the potential failure of atrial sensing, leading to a loss of atrio-ventricular synchrony. This single-centre study aimed to evaluate the prevalence of loss of atrial sensing and its potential determinants in patients with VDD pacemakers. 142 patients with an implanted VDD device underwent long-term follow-up with clinical evaluation, electrocardiogram, device interrogation and echocardiogram. Over a long follow-up period [median 110 (68-156) months], 17 patients (12%) in sinus rhythm presented loss of atrial sensing. This was most often intermittent, but three patients required a permanent switch to VVI mode. ECG showed higher prevalence of interatrial blocks (50% vs 26.6%, p = 0.057) and longer P wave duration (116 ± 19 vs 105 ± 15 ms, p = 0.019) in patients with loss of atrial sensing. Echocardiography revealed larger left atrial (LA) volumes (p < 0.05) in patients with loss of atrial sensing, and lower LA ejection fraction (0.40 vs 0.47, p = 0.0037) and expansion index (0.63 ± 0.26 vs 0.90 ± 0.31, p = 0.003). P wave duration on ECG proved to be independently associated with loss of atrial sensing on multivariable analysis (OR 1.062, 95% CI 1.015-1.110; p = 0.008). The prevalence of atrial fibrillation and subsequent switch to VVI mode was high (16%). In the long-term follow-up, the loss of atrial sensing is present in 12% of patients with implanted VDD pacemakers. ECG and echocardiographic parameters may serve as screening tools for the detection of atrial myopathy which is associated with the loss of atrial sensing.

Sections du résumé

BACKGROUND
VDD pacemakers are regarded as a second choice in patients with atrio-ventricular blocks mainly due to the potential failure of atrial sensing, leading to a loss of atrio-ventricular synchrony. This single-centre study aimed to evaluate the prevalence of loss of atrial sensing and its potential determinants in patients with VDD pacemakers.
METHOD
142 patients with an implanted VDD device underwent long-term follow-up with clinical evaluation, electrocardiogram, device interrogation and echocardiogram.
RESULTS
Over a long follow-up period [median 110 (68-156) months], 17 patients (12%) in sinus rhythm presented loss of atrial sensing. This was most often intermittent, but three patients required a permanent switch to VVI mode. ECG showed higher prevalence of interatrial blocks (50% vs 26.6%, p = 0.057) and longer P wave duration (116 ± 19 vs 105 ± 15 ms, p = 0.019) in patients with loss of atrial sensing. Echocardiography revealed larger left atrial (LA) volumes (p < 0.05) in patients with loss of atrial sensing, and lower LA ejection fraction (0.40 vs 0.47, p = 0.0037) and expansion index (0.63 ± 0.26 vs 0.90 ± 0.31, p = 0.003). P wave duration on ECG proved to be independently associated with loss of atrial sensing on multivariable analysis (OR 1.062, 95% CI 1.015-1.110; p = 0.008). The prevalence of atrial fibrillation and subsequent switch to VVI mode was high (16%).
CONCLUSIONS
In the long-term follow-up, the loss of atrial sensing is present in 12% of patients with implanted VDD pacemakers. ECG and echocardiographic parameters may serve as screening tools for the detection of atrial myopathy which is associated with the loss of atrial sensing.

Identifiants

pubmed: 32987050
pii: S0167-5273(20)33844-4
doi: 10.1016/j.ijcard.2020.09.063
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

62-68

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Auteurs

Giuseppe D Sanna (GD)

Clinical and Interventional Cardiology, Sassari University Hospital, Sassari, Italy. Electronic address: giuseppe.sanna@aousassari.it.

Giuseppe Nusdeo (G)

Clinical and Interventional Cardiology, Sassari University Hospital, Sassari, Italy. Electronic address: gnusdeo@uniss.it.

Alessandro Marini (A)

Clinical and Interventional Cardiology, Sassari University Hospital, Sassari, Italy.

Maria Luisa Ganga (ML)

Clinical and Interventional Cardiology, Sassari University Hospital, Sassari, Italy.

Enrico Mura (E)

Clinical and Interventional Cardiology, Sassari University Hospital, Sassari, Italy.

Mauro Pisano (M)

Clinical and Interventional Cardiology, Sassari University Hospital, Sassari, Italy.

Giuseppe Sabino (G)

Clinical and Interventional Cardiology, Sassari University Hospital, Sassari, Italy.

Guido Parodi (G)

Clinical and Interventional Cardiology, Sassari University Hospital, Sassari, Italy. Electronic address: gparodi@uniss.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH